Cited by 36Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment

Szubert, M., Suzin, J., Duechler, M., Szulawska, A., Czyz, M., Kowalczyk-Amico, K.·2014·Reproduction, Fertility and Development

Abstract

Angiogenesis and inflammation are pivotal processes in developing endometriosis in the peritoneal cavity. The aim of the present study was to evaluate these two processes in women with endometriosis who had been treated with danazol to determine the sensitivity of a non-invasive test in diagnosing endometriosis. The clinical follow-up study was conducted in a group of 103 women diagnosed laparoscopically with endometriosis. Thirty-five patients qualified for danazol treatment. Pain was assessed using a visual analogue scale, whereas endometriosis was assessed using the revised American Society of Reproductive Medicine (rASRM) scale. Cancer antigen (CA)-125 and C-reactive protein (CRP) concentrations in plasma and peritoneal fluid were determined by immunoenzymatic methods, whereas vascular endothelial growth factor (VEGF) and interleukin (IL)-1ß concentrations in plasma and peritoneal fluid were determined by ELISA. Endometrial expression of IL-8 and platelet-derived growth factor alpha polypeptide (PDGF-A) was determined using real-time polymerase chain reaction (PCR). Women with endometriosis (68.9% of patients) had higher plasma concentrations of CA-125, as well as higher concentrations of both CA-125 and VEGF in the peritoneal fluid. Endometrial expression of IL-8 mRNA was significantly higher, whereas that of PDGF-A was significantly lower, in contrast. After danazol treatment the patients reported lower pain scores; in addition, CA-125 concentrations in the plasma were decreased (P < 0.001), whereas VEGF concentration in the plasma increased (P = 0.009). For the diagnosis of endometriosis, none of the combinations of given markers had a sensitivity >60%. Danazol treatment is highly effective in relieving pain and decreasing CA-125 concentrations in the plasma. Higher plasma concentrations of VEGF after treatment could imply stimulation of angiogenesis.

Integrity signals

Registry

Crossref · 10.1071/rd12258

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Danazol treatment of endometriosis patients resulted in an increased VEGF concentration in plasma.

    “In another study, danazol treatment of endometriosis patients resulted in an increased VEGF concentration in plasma [70].”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [70]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Szubert, M., Suzin, J., Duechler, M., Szulawska, A., Czyz, M., & Kowalczyk-Amico, K.
Affiliations
  • Medical University of Lodz (PL)
  • Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk (PL)
  • CDepartment of Molecular Biology of Cancer of Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Corresponding author
Szubert, M.
Venue
Reproduction, Fertility and Development
Published
2013-04-02
Volume
26
Issue
3
Pages
414-420
ISSN
  • 1031-3613 (ISSN-L)
  • 1448-5990
OpenAlex
W2103648079
Cited by
36
References
37
Citations by year
2026: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 1
FWCI
3.62
Type
journal article
Language
en
Open access
closed
Locations
  • Reproduction Fertility and Development (publishedVersion)
  • PubMed (publishedVersion)
Funders
Fundacja na rzecz Nauki Polskiej
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, danazol, angiogenesis, inflammation, CA125, vascular endothelial growth factor, C-reactive protein, IL-1β, interleukin-8, PDGF-A, endometrial gene expression, endometriosis-associated pain, non-invasive diagnosis, treatment response
MeSH terms
Ascitic Fluid, C-Reactive Protein, Danazol, Endometriosis, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Inflammation, Neovascularization, Pathologic, Pain Measurement, Platelet-Derived Growth Factor, Sensitivity and Specificity, Biomarkers, Interleukin-8, CA-125 Antigen, Vascular Endothelial Growth Factor A, Interleukin-1beta, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review